Strongest Q2 Production Yet: Continue to Hold ExxonMobil Stock
Before analyzing the factors driving this positive outlook, let's first review the second-quarter results.
XOM's Q2 Earnings Snapshot
ExxonMobil reported earnings per share of $1.64 (excluding identified items), which beat the Zacks Consensus Estimate of $1.49. The bottom line declined from the year-ago level of $2.14.
Total quarterly revenues of $81.5 billion missed the Zacks Consensus Estimate of $82.8 billion. The top line declined from the year-ago figure of $93.06 billion.
Chevron Corporation CVX and BP plc BP are two other prominent integrated energy companies. While CVX has already posted results, BP will report tomorrow.
Two Highly Profitable Upstream Assets of ExxonMobil
ExxonMobil has a strong presence in offshore Guyana resources and the Permian, the most productive basin in the United States.
The integrated energy company announced that it discovered a massive amount of oil—nearly 11 billion barrels—off the coast of Guyana. To put it simply, this is the largest oil discovery anywhere in the world in the last 15 years. In the region, there are three active projects currently for XOM, combinedly producing at a rate of roughly 650,000 barrels per day. XOM expects a total of eight projects in the region to be online by 2030, which will produce a combined 1.7 million barrels of oil equivalent per day (MMBoE/D).
In the Permian, the energy giant is employing advanced technology to get much more oil out of each well, thereby improving oil recovery. From the most prolific basin, XOM is expecting to produce 2.3 MMBoE/D by the end of this decade, suggesting a surge from the current 1.6 MMBoE/D.
XOM Revises Pioneer Acquisition Synergy Estimates Upward
With a strong focus on strengthening its presence in the Permian, ExxonMobil completed the acquisition of Pioneer Natural Resources Company on May 3, 2024. With 1.4 million net acres of the combined company in the Delaware and Midland basins, having an estimated 16 billion barrels of oil equivalent resource, ExxonMobil has greatly transformed its upstream portfolio.
The Pioneer Natural acquisition's average annual synergy, which XOM earlier estimated at roughly $2 billion over 10 years, has now been revised upward to more than $3 billion annually. The integrated giant now believes the average number could be even more.
How the Diversified Energy Majors CVX, BP Fared in Q2
Chevron reported adjusted second-quarter earnings per share of $1.77, beating the Zacks Consensus Estimate of $1.70. The outperformance stemmed from higher-than-expected production in the company's key upstream segment.
However, the bottom line came well below the year-ago adjusted profit of $2.55 due to weaker oil price realizations.
CVX generated revenue of $44.8 billion. The sales figure missed the Zacks Consensus Estimate of $47.1 billion and decreased 12.4% year over year.
The Zacks Consensus Estimate for BP's earnings is pegged at 68 cents per share, suggesting a year-over-year decline of 32%.
Should Investors Bet on XOM Stock Right Away?
Despite the positive developments, ExxonMobil has gained only a modest 3.8% year to date, possibly due to intensifying trade tensions, which have made the overall market uncertain.
Notably, ExxonMobil admits it's still unsure whether projects like blue hydrogen (a cleaner fuel) and lithium (used in EV batteries) will generate enough profit to be worthwhile. While these are promising long-term opportunities, their high risk and uncertainty may weigh on the stock price.
YTD Price Chart
Coming to the valuation story, the stock is trading at a 7.12x trailing 12-month Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization (EV/EBITDA), which is at a premium compared with the broader industry average of 4.31x.
Thus, considering the uncertainty and expensive valuations, it might not be the right time to bet on the stock. Those who have already invested may retain XOM, which carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Zacks Names #1 Semiconductor Stock
This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BP p.l.c. (BP): Free Stock Analysis Report
Chevron Corporation (CVX): Free Stock Analysis Report
Exxon Mobil Corporation (XOM): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
8 minutes ago
- Globe and Mail
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ('iSpecimen' or the 'Company'), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to pay $500,000 for marketing and advertising services to be provided by IR Agency LLC, and the remainder for working capital and general corporate purposes. In connection with the offering, the Company issued 1,559,828 shares of common stock (or pre-funded warrants to purchase shares of common stock) at a purchase price of $1.122 per share, priced at-the-market under Nasdaq rules. The offering closed on August 4, 2025. WestPark Capital, Inc. acted as the exclusive placement agent in connection with the offering. Additional details regarding the offering will be available in a Form 8-K to be filed by the Company with the Securities and Exchange Commission (the "SEC"). The securities described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About iSpecimen iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit Safe Harbor Statement Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The reader is cautioned not to rely on such forward-looking statements. Such forward-looking statements relate to future events or our future performance. In evaluating these forward-looking statements, you should consider various factors, including the uncertainty regarding future commercial success; risks and uncertainties associated with market conditions and the Company's ability to satisfy the closing conditions related to the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions and actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 14, 2025, as well as other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, iSpecimen specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Toronto Star
24 minutes ago
- Toronto Star
Pacific Green Signs Commitment Agreement With ZEN Energy for BESS Offtake in Australia for 1.5GWh
Sydney, Aug. 05, 2025 (GLOBE NEWSWIRE) — - Pacific Green is pleased to announce that its battery energy storage business in Australia has entered into a commitment agreement with ZEN Energy ('ZEN') for 10-year tolling arrangements across three Battery Energy Storage System (BESS) projects located in Victoria, New South Wales, and Queensland totaling 1.5GWh of storage capacity. This milestone marks a pivotal step in Pacific Green's transition to its next phase of growth, significantly accelerating the route to market for its Australian project portfolio of 7GWh. Scott Poulter, Pacific Green's Group CEO, commented: 'Following our initial offtake agreement of 500MWh for Limestone Coast North in South Australia, we are delighted to enter into a strategic framework for a further 1.5GWh. This framework agreement helps Pacific Green underwrite a significant part of the our portfolio of developments in Victoria, New South Wales and Queensland, and enables Pacific Green to industrialize its project development processes.'
Globe and Mail
38 minutes ago
- Globe and Mail
Why SES AI Stock Surged 13% Higher Today
Key Points It regained compliance with New York Stock Exchange listing requirements. These stipulate that a stock must trade at a trailing average of $1 per share. 10 stocks we like better than Ses Ai › One trading day can make quite a difference in the life of a stock. This was well on display Monday with next-generation electric vehicle (EV) battery developer SES AI (NYSE: SES). The company's share price leaped more than 13% skyward on some good news with its stock listing. That advance was more than strong enough to crush the 1.5% increase of the bellwether S&P 500 index. An electric announcement SES AI disclosed in a regulatory filing Monday, no doubt with immense relief, that it received notice from the New York Stock Exchange that it had regained compliance with the bourse's listing requirement. Specifically, this mandates that a stock on the exchange must trade for about $1 per share for a 30-day period. In the tersely worded document, SES AI said NYSE informed the company on Friday, citing the 30-day stretch that ended on July 31. Although SES AI is a relatively early-stage company, it has lately been drawing revenue and attracting notice for its cutting-edge battery solutions. However, the growth of EV sales isn't as robust as it once was, and the company has posted a string of bottom-line losses. Growth by other means Yet SES AI is also a company on the move; in recent days, it has shown an appetite for growing through acquisitions. It concluded a deal to purchase energy storage systems (ESS) developer UZ Energy for a price of around $25.5 million. That acquisition could prove to be rather complementary to its business, assuming it is integrated effectively and efficiently into its operations. Should you invest $1,000 in Ses Ai right now? Before you buy stock in Ses Ai, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ses Ai wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
